J
Juliana Ochulor
Researcher at UCL Institute of Neurology
Publications - 5
Citations - 32
Juliana Ochulor is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Overactive bladder & Percutaneous tibial nerve stimulation. The author has an hindex of 2, co-authored 5 publications receiving 23 citations.
Papers
More filters
Journal ArticleDOI
Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder
Katarina Ivana Tudor,Katarina Ivana Tudor,Jai Seth,Martina D. Liechti,Martina D. Liechti,Juliana Ochulor,Gwen Gonzales,Collette Haslam,Zoe Fox,Mahreen Pakzad,Jalesh N. Panicker +10 more
TL;DR: Percutaneous tibial nerve stimulation appears to be a possible promising alternative for patients with neurological disorder reporting overactive bladder symptoms who find first-line treatments either ineffective or intolerable, however, a properly designed study is required to address safety and efficacy.
Journal ArticleDOI
Percutaneous tibial nerve stimulation for overactive bladder
Katarina Ivana Tudor,Jai Seth,Juliana Ochulor,Martina D. Liechti,Zoe Fox,Gwen Gonzales,Collette Haslam,Mahreen Pakzad,Sohier Elneil,Jalesh N. Panicker +9 more
TL;DR: Percutaneous Tibial Nerve Stimulation is a safe and effective treatment in patients with neurological disorders, associated with significant improvements in overactive bladder symptoms and quality of life.
Journal Article
Single centre randomised pilot study of two regimens (30mins daily or 30mins weekly for 12 weeks) of Transcutaneous Tibial Nerve Stimulation using an adhesive skin patch for the treatment of Overactive Bladder (OAB) Symptoms
Jai Seth,Gwen Gonzales,Collette Haslam,Juliana Ochulor,Sohier Elneil,Arvind Vashisht,Arun Sahai,Charles H. Knowles,Art Tucker,Jalesh N. Panicker +9 more
Journal Article
Percutaneous tibial nerve stimulation for the management of the idiopathic and neurogenic overactive bladder: A safe and effective treatment
Jai Seth,Katarina Ivana Tudor,Martina D. Liechti,Juliana Ochulor,Gwen Gonazales,Collette Haslam,Zoe Fox,Mahreen Pakzad,Sohier Elneil,Jalesh N. Panicker +9 more
TL;DR: This is a prospective evaluation over 18 months of patients who found first line treatments intolerable or ineffective, and patients opting to continue treatment after 12 weeks returned for top-up session.
Journal ArticleDOI
Mp26-07 intravesical onabotulinumtoxin-a injections decrease both nerve growth factor and brain derived neurotrophic factor levels in bladder tissue and urine in patients with idiopathic and neurogenic detrusor overactivity
TL;DR: In this paper, the impact of intravesical injections of BTX-A on neurotrophin activity in patients with idiopathic and neurogenic detrusor overactivity was investigated.